Search

everythinglearnresearchcommunity

for

Search:↓

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Genetic defects in the glucocorticoid receptor gene can cause conditions with abnormal sensitivity to stress hormones, and other factors may also affect this sensitivity.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Hashimoto thyroiditis is an autoimmune disease that can lead to an underactive thyroid and is treated with medication and sometimes diet changes or surgery.

Long-term glucocorticoid use can cause skin problems like easy bruising and poor wound healing, especially at higher doses.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Exosomes helped regrow hair in a 14-year-old with difficult-to-treat alopecia.

Synthetic curcumin derivatives improve treatment for diabetes and cancer.

Activating TLR3 helps improve skin and hair follicle regeneration after wounds.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Untreated congenital adrenal hyperplasia can lead to complications like stroke and needs glucocorticoid treatment.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Mutations in the glucocorticoid receptor gene cause reduced sensitivity to glucocorticoids and may lead to poor response to treatment.

Norethisterone (jenapharm) therapy is effective for endometrial cancer.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

Women with non-classic congenital adrenal hyperplasia have higher risk for heart and metabolic problems.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Androgens can affect glucocorticoid signaling in specific mouse brain areas.

Modern lifestyles, including poor diet, stress, and long-term use of certain medications, hinder the body's ability to heal from inflammation, leading to chronic diseases.